Endoscopy Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.
J Gastroenterol. 2022 Nov;57(11):879-889. doi: 10.1007/s00535-022-01908-1. Epub 2022 Aug 16.
Improved optical diagnostic technology is needed that can be used by also outside expert centers. Hence, we developed an artificial intelligence (AI) system that automatically and robustly predicts the pathological diagnosis based on the revised Vienna Classification using standard colonoscopy images.
We prepared deep learning algorithms and colonoscopy images containing pathologically proven lesions (56,872 images, 6775 lesions). Four classifications were adopted: revised Vienna Classification category 1, 3, and 4/5 and normal images. The best algorithm-ResNet152-in the independent internal validation (14,048 images, 1718 lesions) was used for external validation (255 images, 128 lesions) based on neoplastic and non-neoplastic classification. Diagnostic performance of endoscopists was compared using a computer-assisted interpreting test.
In the internal validation, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for adenoma (category 3) of 84.6% (95% CI 83.5-85.6%), 99.7% (99.5-99.8%), 90.8% (89.9-91.7%), 89.2% (88.5-99.0%), and 89.8% (89.3-90.4%), respectively. In the external validation, ResNet152's sensitivity, specificity, PPV, NPV, and accuracy for neoplastic lesions were 88.3% (82.6-94.1%), 90.3% (83.0-97.7%), 94.6% (90.5-98.8%), 80.0% (70.6-89.4%), and 89.0% (84.5-93.6%), respectively. This diagnostic performance was superior to that of expert endoscopists. Area under the receiver-operating characteristic curve was 0.903 (0.860-0.946).
The developed AI system can help non-expert endoscopists make differential diagnoses of colorectal neoplasia on par with expert endoscopists during colonoscopy. (229/250 words).
需要改进光学诊断技术,以便即使在非专家中心也能使用。因此,我们开发了一种人工智能(AI)系统,该系统可使用标准结肠镜图像自动且稳健地基于修订后的维也纳分类法预测病理诊断。
我们准备了深度学习算法和包含经病理证实的病变的结肠镜图像(56872 张图像,6775 个病变)。采用了四种分类:修订后的维也纳分类法第 1、3 和 4/5 类以及正常图像。在独立的内部验证中(14048 张图像,1718 个病变),最佳算法-ResNet152-用于基于肿瘤和非肿瘤分类的外部验证(255 张图像,128 个病变)。使用计算机辅助解释测试比较了内镜医生的诊断性能。
在内部验证中,对于腺瘤(第 3 类)的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确率分别为 84.6%(95%CI 83.5-85.6%)、99.7%(99.5-99.8%)、90.8%(89.9-91.7%)、89.2%(88.5-99.0%)和 89.8%(89.3-90.4%)。在外部验证中,ResNet152 对肿瘤性病变的敏感性、特异性、PPV、NPV 和准确率分别为 88.3%(82.6-94.1%)、90.3%(83.0-97.7%)、94.6%(90.5-98.8%)、80.0%(70.6-89.4%)和 89.0%(84.5-93.6%)。该诊断性能优于专家内镜医生。受试者工作特征曲线下面积为 0.903(0.860-0.946)。
所开发的 AI 系统可以帮助非专家内镜医生在结肠镜检查期间对结直肠肿瘤进行与专家内镜医生相当的鉴别诊断。(229/250 字)